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Abstracts / Osteoarthritis and Cartilage 20 (2012) S10–S53S44Sost mRNA suggesting that Sclerostin might be regulated by Wnt. We
further observed an enhanced expression of Sclerostin in osteoarthritic
cartilage compared to cartilage of control mice.
Conclusions:We here show that Wnt3a increases the catabolic activity
and inhibits the anabolic activity in murine chondrocytes. Sclerostin
alleviates the expression of catabolic genes induced byWnt and rescued
proteoglycan production. Moreover, Sclerostin promotes the cartilage
maintenance through the inhibition of chondrocyte hypertrophy.
Finally, the expression of Sclerostin expression in osteoarthritic mice
suggests that Sclerostin might be involved in the pathophysiology in
cartilage damage and might constitute a target for the prevention of
osteoarthritis.
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ROLE OF STROMAL CELL-DERIVED FACTOR-1 ALPHA ON
ENDOCHONDRAL OSSIFICATION
G. Kim 1,2, S. Han 1,2, Y. Jung 2, S. Usmani 3,4, V. Ulici 3,4,
F. Beier 3,4. 1Daegu fatima Hosp., Daegu, Republic of Korea; 2 Lab. for
arthritis and bone biology, Fatima research Inst., Daegu, Republic of
Korea; 3Dept. of Physiology and Pharmacology, Univ. of Western
Ontario, London, ON, Canada; 4CIHR Group in Skeletal Dev. and
Remodeling, London, ON, Canada
Purpose: The main cellular events of articular chondrocytes during
osteoarthritis are a loss of the traits as permanent cartilage, and
a transition to hypertrophic chondrocytes responding to excessive
stress. Aberrant endochondral ossiﬁcation in the articular cartilage,
such as chondrocyte proliferation, differentiation and apoptosis, are
thought to play an important role in the development of osteoarthritis.
The research about molecular mechanisms controlling the endochon-
dral ossiﬁcation in the growth plate of bone thus can give us an
important clue to understand the pathogenesis of osteoarthritis. Several
lines of evidences suggest that the stromal cell-derived factor-1 alpha
(SDF-1a) has been implicated in osteoarthritis, but their exact mecha-
nisms still remains unclear. In this study, we investigated the roles of
SDF-1a on the endochondral ossiﬁcation.
Methods: Primary chondrocytes and tibial explants from embryonic 15.5
day-oldmicewereculturedwithPBSvehicleor recombinantmouseSDF-1a.
Total RNA was isolated from primary cell cultures using a Qiagen RNeasy
Mini Kit. Real-time PCR analysis was performed using Applied Biosystems
7900 HT Real-Time PCR System and TaqMan Gene Expression Assays for
Sox9, Col2a1, Acan, MMP13, Col10a1, Runx2. Organ culture tissues were
stained with safranin O/fast green and alcian blue/alizarin red, and the
immunohistochemistry was also performed on tissue sections with anti-
Caspase3, anti-MMP13, anti-Runx2, anti-COL10, anti-proliferating chon-
drocyte nuclear antigen (PCNA) and anti-SOX9 antibodies
Results:Primarychondrocyte cultures revealed that SDF-1a signiﬁcantly
increased the expression of aggrecan and Col10a1 which is a marker for
chondrocyte proliferation and hypertrophy, respectively (p<0.05). The
master regulator gene of chondrocyte hypertrophy, Runx2, was also up-
regulated in messenger RNA level by SDF-1a (p<0.05). To gain further
insights into the role of SDF-1a on endochondral ossiﬁcation, we
examined the effects of SDF-1a in tibia organ cultures. The length of
tibias, comparedwith the controls, was signiﬁcantly increased in SDF-1a
treatment group (p<0.05). Immunohistochemical staining of organ
cultures agreed with the morphologic ﬁnding; the expression of PCNA,
themarker for chondrocyteproliferationandSox9markedly increased in
chondrocytes of proliferating zone. In addition to proliferation marker,
type 10 collagen, the marker for hypertrophy and Caspase3, were up-
regulated in hypertrophic zone by SDF-1a.
Conclusions: Our ﬁndings reveal that SDF-1a has an effect on chon-
drocyte proliferation, hypertrophy and apoptosis during endochondral
ossiﬁcation through Sox9 and Runx2. SDF-1a thus may represent
a therapeutic target of osteoarthritis.
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NG2/CSPG4 REGULATES AGGRECANASE AND MMP EXPRESSION IN
HUMAN CHONDROCYTES
N.S. Jamil, A. Azfer, H.E. Sarah, D.M. Salter. Univ. of Edinburgh, Edinburgh,
United Kingdom
Purpose: NG2/CSPG4 is a chondroitin sulphate rich transmembrane
proteoglycan. It is expressed by a number of different cell types
including neuronal cells and melanocytes and appears to be involved inregulation of cell migration, spreading, proliferation and death.
Expression in developing and adult cartilage has been recognised for
some time but less is known of its roles in regulating chondrocyte
function. The purpose of the study was to investigate expression and
interactions of NG2/CSPG4 in chondrocytes and establish whether this
molecule is involved in regulation of gene expression of cartilage
speciﬁc molecules and proteases involved in cartilage breakdown.
Methods: Chondrocytes from osteoarthritic human articular cartilage
(OA), C20A4, an immortalised chondrocyte cell line and JJ012, grade II
chondrosarcoma cell line were used. NG2/CSPG4 expression was
investigated by immunoﬂuorescence, western blotting and RT-PCR.
Interactions within the Golgi complex and endoplasmic reticulumwere
assessed by double immunoﬂuorescence. Biochemical interactions
were assessed by immunoprecipitation and mass spectroscopy. Roles in
gene regulation were studied by shRNA knockdown of NG2/CSPG4 in
JJ012 cells and assessment of gene expression by RTPCR.
Results: NG2/CSPG4 was expressed by all cells studied. Western blot-
ting of extracts from OA chondrocytes showed molecular weight forms
of around 400, 270 and 55kD without chondroitinase treatment and
four forms of 270 238, 117 and 55kD following chondroitinase pre-
treatment. NG2/CSPG4 was distributed predominantly at the cell
surface of JJ012 cells. In OA chondrocytes distribution was both as the
cell surface and within the cytoplasm with double
immunoﬂuorescence indicating that NG2 is localised with the Golgi
complex but not the ER. Immunoprecipitation and mass spectrometry
data demonstrated associations between NG2/CSPG4 and both
collagen VI and thrombospondin in OA chondrocytes. Following NG2
knockdown in JJ012 cells there was no difference in expression of
aggrecan, collagen II and SOX-9. In contrast cells in which NG2/CSPG4
had been knocked down showed decreased expression of MPP3 and
ADAMTS-4, a complete loss of ADAMTS-5 and increased expression of
MMP13.
Conclusions: In this study we have identiﬁed expression of multiple
forms of NG2/CSPG4 in human OA chondrocytes and shown association
of this molecule with type VI collagen and thrombospondin. Loss of
NG2/CSPG4 induced changes in expression of aggrecanases and MMPs.
Altered expression or associations of NG2/CSPG4 with extracellular
ligands or intracellular signalling cascades may be important in the
pathogenesis of OA by regulating proteolytic activity or apoptosis
related pathways.
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ACTIVATION OF AMP-ACTIVATED PROTEIN KINASE (AMPK) INHIBITS
CHONDROCYTE CATABOLIC RESPONSE TO PRO-INFLAMMATORY
CYTOKINES AND UP-REGULATES ANTI-OXIDANT GENES VIA PPARg
COACTIVATOR 1a (PGC-1a) AND FORKHEAD BOX O FACTOR 3
(FOXO3A)
X. Zhao 1, R. Terkeltaub 1, M. Lotz 2, R. Liu-Bryan 1. 1VAMC, UCSD, San
Diego, CA, USA; 2 The Scripps Res. Inst., La Jolla, CA, USA
Purpose: AMPK is a super-regulator of cellular energy homeostasis and
metabolism.We have previously reported that AMPK activity is reduced
in human knee OA articular chondrocytes and in cultured primary
normal chondrocytes stimulated with inﬂammatory cytokines IL-1b
and TNFa. AMPK pharmacologic activators suppress chondrocyte
catabolic responses to IL-1b and TNFa by inhibition of NF-kB activation.
In addition, we observed that AMPK activity is promoted by upstream
kinase LKB1 and inhibited by protein phosphatase PP2Ca in articular
chondrocytes. Because PGC-1a (a master regulator of mitochondria
biogenesis) and FOXO3a (a direct transcriptional regulator of PGC-1) are
downstream targets of AMPK that have been shown to mediate anti-
inﬂammatory effect of AMPK and regulate oxidative stress protect
genes, we tested if PGC-1a and FOXO3a mediate AMPK to inhibit
catabolic responses induced by IL-1b and TNFa, and regulate expression
of anti-oxidant genes such as manganese superoxide dismutase
(MnSOD or SOD2), catalase and thioredoxin in articular chondrocytes.
Methods: Expression of PGC-1a or FOXO3a in normal human knee
articular chondrocytes was knocked down via siRNA transfection. These
knockdown chondrocytes were then stimulated with IL-1b (10 ng/ml)
and TNFa (20 ng/ml). Phosphorylation of p65 (Ser536) NF-kB subunit
was examined at 4 hours after stimulation by Western blot analysis.
Pro-catabolic responses including nitric oxide (NO) generation and
expression of MMP-3 assessed by Griess reaction and Western Blot
analysis, respectively, at 18 hours after stimulation. Additionally, mouse
chondrocytes isolated from femoral head cartilages of AMPKa1
Abstracts / Osteoarthritis and Cartilage 20 (2012) S10–S53 S45knockout (KO) and wild type (WT) mice, or WT mouse chondrocytes
treated with AMPK pharmacologic activator AICAR were subjected to
Western blot analyses for expression of PGC-1a, FOXO3a, SOD2, catalase
and thioredoxin.
Results: NF-kB activation (Ser536 phosphorylation p65 NF-kB), NO
generation and MMP-3 expression induced by IL-1b and TNFa were
enhanced in primary human knee articular chondrocytes with knock-
down of PGC-1a or FOXO3a. In addition, decreased expression of PGC-
1a and FOXO3a, correlated with decreased expression of SOD2, catalase
and thioredoxin, was observed in AMPKa1 KO chondrocytes, compared
with WT chondrocytes. Conversely, activation of AMPK by AICAR
signiﬁcantly increased expression of SOD2, catalase and thioredoxin in
chondrocytes.
Conclusions: Activation of AMPK-PGC-1a and AMPK-FOXO3a pathways
maintain the cellular redox balance in articular chondrocytes by up-
regulating anti-oxidant genes, and inhibit chondrocyte catabolic
responses to inﬂammatory cytokines.
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TOWARDS GENE-BASED ANALYSIS OF GENOME-WIDE ASSOCIATION
OSTEOARTHRITIS DATA
A. Gonzalez 1, C. Rodriguez-Fontenla 1, M. Calaza 1, E. Evangelou 2,
J.J. Gomez-Reino 1. Translation Research in Europe Applied
Technologies for Osteoarthritis (TreatOA)1Hosp. Clinico Univ.rio de
Santiago, Santiago de Compostela, Spain; 2Univ. of Ioannina Sch. of
Med., Ioannina, Greece
Purpose: New tools are being developed to extract additional infor-
mation from Genome-Wide Associations studies (GWAS) beyond the
comparisons involving a SNP at a time. A promising area involves
generating a single global statistic for each gene by combining associ-
ation data from each SNP in its locus, hence called Gene-Based Analysis
(GBA). This approach will be particularly useful for genes with multiple
susceptibility polymorphisms of small effect and for genes with several
low frequency susceptibility variants of relative high effect. However,
there are still many standing questions that need to be addressed before
GBA could be widely accepted. We have explored the feasibility of using
GBA for the elucidation of OA genetics.
Methods: We used an approach that accounts for linkage disequilib-
rium between SNPs. This involved the use of statistical tests that take
into account dependence between SNPs deﬁned by the LD structure of
each gene. In addition, we have incorporated information about genetic
recombination for the deﬁnition of each gene. Gene coordinates were
taken from a human genome database (UCSC hg18). This information
was combined with the deCODE recombination maps to deﬁne gene
boundaries [1]. Overlapping genes were combined in a single locus.
About 2.5 million SNPs and their respective p values were taken from
a meta-analysis of 9 OA GWAS [2]. Their positions in the genes were
obtained fromHapMap Phase II+III (rel28) as well as the genotypes used
to obtain the pairwise r squaredmatrix of LD in each locus. This analysis
was done with PLINK. Four different statistics were used to combine p
values from all SNPs in each gene: linear combination test (LCT),
quadratic test (QT), decorrelation test (DT) and Fisher test with an
approximation for dependent p values (FT) [3,4]. All analyses were done
in a cluster of Unix nodes (SVG.CESGA.es).
Results: Combination of the genomic coordinates of 18022 human
genes and the recombination (sex-averaged) map gave 7125 non-
overlapping loci. These loci contained from 1 to 61 geneswith amean of
2.5 genes. Median size of these loci was 170 Kb (IQR 90-300 Kb). First
analyses showed that SNPs with minor allele frequency (MAF) below 5
% disproportionally contributed to the increased complexity of the LD
pattern and to a reduction of the power of statistics accounting for LD.
Therefore, the GBA was performed in two parts: SNPs with MAF over 5
%, with approaches that accounted for LD; and for SNPs withMAF below
5 %, without accounting for LD (not pursued here). For the ﬁrst part, 1.23
million SNPs with p values from the OA GWAS meta-analysis and MAF
larger than 5 % were contained in the genes (median ¼ 117, IQR 60-216).
A pilot study with 100 randomly chosen genes plus two known OA
susceptibility loci (GDF5 and 7q22) showed that two statistics (LCT and
FT) performed reasonably well. They indentiﬁed the two known loci as
the most associated. The other two statistics did not identify any of
them.
Conclusions: There are still obstacles for the use of GBA to extract more
information from OA GWAS data. We have found that two separate
analyses are required because the low frequency SNPs add too muchcomplexity to analyses accounting for the LD structure of the genes. For
SNPs of MAF over 5 %, we have found that all the process including two
of the described statistics perform reasonable well. The other two tests
still do not work adequately. Concordance between the different
statistics is desirable to increase conﬁdence in the results and we
continue working to obtain it by improving deﬁnition of the LD
structure.
1. Kong A, et al. Nature (2010): 28;467:1099-103.
2. Evangelou E. et al. Unpublished.
3. Luo L, et al. Eur J Hum Genet. (2010);18:1045-53.
4. Kost.J.T, McDermott M.P. Statistics and Probability Letters. (2002); 60:
183-190.
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THE OSTEOARTHRITIS SUSCEPTIBILITY GENE GDF5 IS UNDER
EPIGENETIC REGULATION BY DNA METHYLATION - THE
MOLECULAR INTERPLAY BETWEEN GENETICS AND EPIGENETICS IN
DISEASE RISK
L.N. Reynard, C.M. Syddall, J. Loughlin. Newcastle Univ., Newcastle upon
Tyne, United Kingdom
Purpose: GDF5 is involved in chondrogenesis, synovial joint mainte-
nance and repair, and is essential for normal skeletal, bone and joint
development. The rs143383 C to T SNP within the GDF5 50UTR is
associated with OA susceptibility and with susceptibility to other
musculoskeletal phenotypes. rs143383 exerts a joint-wide effect on
GDF5 expression, with expression of the OA-associated T allele being
signiﬁcantly reduced relative to the C allele, a phenomenon termed
differential allelic expression (DAE). We have previously reported that
the GDF5 promoter and 5'UTR are subject to DNAmethylation in human
cell lines and in the soft joint tissues meniscus, fat pad, ligament, and
synovium, and that demethylation of speciﬁc CpG dinucleotides within
the 5'UTR is associated with an increase in the DAE of rs143383. In this
study, we performed a focussed and detailed analysis of the methyla-
tion status of the GDF5 locus in cartilage, the principal tissue affected in
OA and one which we have not examined before. Our aims were to (1)
determine if DNA methylation regulates GDF5 expression in chon-
drocytes, and (2) understand how demethylation of speciﬁc CpG sites in
the 5'UTR affects the DAE of rs143383 and thus OA susceptibility.
Methods: Human articular chondrocytes (HACs) were cultured with
5mM of the demethylating agent 5-aza-2’deoxycytidine (AZA), and gene
expression and DNA methylation assessed by qRT-PCR and bisulphite
sequencing. Macroscopically normal cartilage was obtained from OA
patients who had undergone either total hip (n¼11) or total knee
(n¼13) replacement surgery, with cartilage from fractured neck of
femur (NOF, n¼15) patients used as a non-OA control. Genomic DNA
was extracted, bisulphite converted and methylation of the GDF5 locus
analysed by either pyrosequencing or cloning and Sanger sequencing.
Electrophoretic mobility shift assays (EMSAs) were used to analyse how
methylation of the CpG site at +37 located 3bp upstream of rs143383
affected binding of transacting factors to the C and T alleles of this SNP
and whether this affected GDF5 DAE.
Results: GDF5 transcription was signiﬁcantly increased in HACs
exposed to AZA relative to control cells, with the extent of upregulation
varying between patients from 2.3 to 5.4 fold. There were signiﬁcant
differences in the total methylation of the GDF5 locus in cartilage from
NOF, OA hip and OA knee patients, with the GDF5 CpG island being
signiﬁcantly hypomethylated in OA knee (p<0.0005) and hip (p<0.015)
relative to NOF. The GDF5 5'UTR was also hypomethylated in OA knee
cartilage, with the greatest demethylation observed at the +37 and +106
CpG sites; we have previously demonstrated that AZA-induced deme-
thylation of these sites correlates with increased DAE of rs143383 in-
vitro. A more detailed molecular analysis of how the +37 CpG site
upstream of the rs143383 SNP affects DAE of this SNP was performed
using EMSAs. These demonstrated that methylation of the +37 CpG site
reduced binding of protein complexes to the T allele but not the C allele
of rs143383. This suggests that the AZA induced increase in DAE of
rs143383 we observed previously is the result of increased binding of
a repressor(s) to the T allele of rs143383 caused by the demethylation at
the +37 CpG site.
Conclusions: The methylation status of the +37 CpG site has a signiﬁ-
cant effect on the binding of transcriptional repressors to the T allele of
rs143383, demonstrating that DNA methylation modulates the genetic
effect of the OA-associated SNP rs143383 on GDF5 gene expression. The
inter-individual variability in DAE of rs143383 can therefore be
